AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9767368 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin 0.25 mg twice daily for 10 days
Number of subjects: 22
Study 9767368 — intervention group
Group type: EXPERIMENTAL
Intervention: Digitoxin 0.1 mg daily for 10 days
Number of subjects: 22
Study 9767368 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 8121439 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV DNA detected by polymerase chain reaction (PCR)
Number of subjects: 525
Study 8121439 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal factors (oral contraceptives and high parity)
Number of subjects: 525
Study 3113804 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil (125 mg, twice daily)
Number of subjects: 93
Study 3113804 — intervention group
Group type: COMPARATOR
Intervention: Phenoxymethyl penicillin (250 mg, three times daily)
Number of subjects: 93
Study 3113804 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil
Number of subjects: 93
Study 3113804 — intervention group
Group type: COMPARATOR
Intervention: Phenoxymethyl penicillin
Number of subjects: 93
Study 30025748 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective removal (SE)
Number of subjects: 74
Study 30025748 — intervention group
Group type: COMPARATOR
Intervention: Stepwise removal (SW)
Number of subjects: 74
Study 27323167 — intervention group
Group type: EXPERIMENTAL
Intervention: BRS 308 genotype
Number of subjects: 25
Study 27323167 — intervention group
Group type: EXPERIMENTAL
Intervention: 1G282 genotype
Number of subjects: 25
Study 26603245 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydration group (n=17) coached to increase water intake by up to 1.5 L/day for 6 weeks
Number of subjects: 28
Study 26603245 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=11) asked to maintain regular water intake
Number of subjects: 28
Study 23659834 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrotalcite
Number of subjects: 253
Study 23659834 — intervention group
Group type: COMPARATOR
Intervention: Esomeprazole
Number of subjects: 253
Study 16178133 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.075% CPC mouthrinse
Number of subjects: 366
Study 16178133 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.10% CPC mouthrinse
Number of subjects: 366
Study 16178133 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 366
Study 16178133 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine rinse
Number of subjects: 366
Study 11792655 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 0.5 mg
Number of subjects: 32
Study 11792655 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 3.0 mg
Number of subjects: 32
Study 11792655 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 10516740 — intervention group
Group type: EXPERIMENTAL
Intervention: Auscultation of Korotkoff sounds inside the cuff
Number of subjects: 151
Study 10516740 — intervention group
Group type: COMPARATOR
Intervention: Auscultation of Korotkoff sounds in the antecubital fossa
Number of subjects: 151
Study 10516740 — intervention group
Group type: EXPERIMENTAL
Intervention: Same-arm test in part B
Number of subjects: 151
Study 10516740 — intervention group
Group type: EXPERIMENTAL
Intervention: Opposite-arm test in part B
Number of subjects: 151
Study 7718752 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 60
Study 7718752 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 60
Study 7718752 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 1784882 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous regional administration of methylprednisolone (40 mg)
Number of subjects: 22
Study 1784882 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 7038051 — intervention group
Group type: COMPARATOR
Intervention: DS103-282
Number of subjects: 0
Study 7038051 — intervention group
Group type: COMPARATOR
Intervention: baclofen
Number of subjects: 0
Study 7038051 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study 30102677 — intervention group
Group type: EXPERIMENTAL
Intervention: α‐HICA
Number of subjects: 40
Study 30102677 — intervention group
Group type: EXPERIMENTAL
Intervention: HMB‐FA
Number of subjects: 40
Study 30102677 — intervention group
Group type: EXPERIMENTAL
Intervention: HMB‐Ca
Number of subjects: 40
Study 30102677 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 40
Study 28726270 — intervention group
Group type: EXPERIMENTAL
Intervention: N2O (nitrous oxide and oxygen)
Number of subjects: 64
Study 28726270 — intervention group
Group type: COMPARATOR
Intervention: Placebo gas
Number of subjects: 64
Study 26164351 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation intervention including inpatient (20 days) or outpatient (18 days) rehabilitation with follow-up, walking exercises with and without body-weight support, and conventional physiotherapy.
Number of subjects: 147
Study 26164351 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation intervention
Number of subjects: 147
Study 22895380 — intervention group
Group type: EXPERIMENTAL
Intervention: 12‐wk supervised exercise program
Number of subjects: 107
Study 21696894 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram (0, 250, and 500 mg/d, p.o.)
Number of subjects: 0
Study 21696894 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (0.4 g/kg i.v.)
Number of subjects: 0
Study 21696894 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine (30 mg i.v.)
Number of subjects: 0
Study 21696894 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram (500 mg/d, p.o.)
Number of subjects: 0
Study 17318205 — intervention group
Group type: EXPERIMENTAL
Intervention: AcrySof IOL
Number of subjects: 91
Study 17318205 — intervention group
Group type: COMPARATOR
Intervention: EPOCH IOL
Number of subjects: 91
Study 16505646 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume, low-pressure (LVLP) cuff
Number of subjects: 105
Study 16505646 — intervention group
Group type: COMPARATOR
Intervention: High-volume, low-pressure (HVLP) cuff
Number of subjects: 105
Study 12767841 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiseptic-impregnated catheters (AIC)
Number of subjects: 390
Study 12767841 — intervention group
Group type: COMPARATOR
Intervention: Non-impregnated catheters (non-AIC)
Number of subjects: 390
Study 12767841 — intervention group
Group type: EXPERIMENTAL
Intervention: Jugular group catheters
Number of subjects: 390
Study 12767841 — intervention group
Group type: COMPARATOR
Intervention: Subclavian group catheters
Number of subjects: 390
Study 10778866 — intervention group
Group type: EXPERIMENTAL
Intervention: Tyrosine intake at varying levels (3.0, 4.5, 6.0, 7.5, 9.0, 10.5, and 12.0 mg x kg(‐1) x d(‐1))
Number of subjects: 0
Study 10778866 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 9051817 — intervention group
Group type: EXPERIMENTAL
Intervention: ACD-CPR in standing position (ACD-S)
Number of subjects: 12
Study 9051817 — intervention group
Group type: COMPARATOR
Intervention: ACD-CPR in kneeling position (ACD-B)
Number of subjects: 12
Study 7870903 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous diazepam (logarithmically increasing doses at 15-min intervals)
Number of subjects: 24
Study 7870903 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 7870903 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous diazepam
Number of subjects: 24
Study 2422994 — intervention group
Group type: EXPERIMENTAL
Intervention: MOPP/ABVD
Number of subjects: 88
Study 2422994 — intervention group
Group type: COMPARATOR
Intervention: MOPP
Number of subjects: 88
Study 29972456 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective caries removal (SCR)
Number of subjects: 36
Study 29972456 — intervention group
Group type: COMPARATOR
Intervention: Complete caries removal (CCR)
Number of subjects: 36
Study 27515750 — intervention group
Group type: EXPERIMENTAL
Intervention: Short message intervention on good household prenatal practices
Number of subjects: 0
Study 27515750 — intervention group
Group type: EXPERIMENTAL
Intervention: Short message intervention on healthcare seeking
Number of subjects: 0
Study 27515750 — intervention group
Group type: EXPERIMENTAL
Intervention: Both short message interventions
Number of subjects: 0
Study 27515750 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 24417772 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir/ritonavir
Number of subjects: 178
Study 24417772 — intervention group
Group type: COMPARATOR
Intervention: Darunavir/ritonavir
Number of subjects: 178
Study 24417772 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir/ritonavir and darunavir/ritonavir
Number of subjects: 178
Study 22838229 — intervention group
Group type: EXPERIMENTAL
Intervention: GIC with 10% bioactive glass (group 5)
Number of subjects: 70
Study 22838229 — intervention group
Group type: COMPARATOR
Intervention: Mineral Trioxide Aggregate (group 8)
Number of subjects: 70
Study 22838229 — intervention group
Group type: EXPERIMENTAL
Intervention: GIC with 0.01% collagen (group 2)
Number of subjects: 70
Study 22838229 — intervention group
Group type: EXPERIMENTAL
Intervention: GIC with 0.1% collagen (group 3)
Number of subjects: 70
Study 22838229 — intervention group
Group type: EXPERIMENTAL
Intervention: GIC with 1% collagen (group 4)
Number of subjects: 70
Study 22838229 — intervention group
Group type: EXPERIMENTAL
Intervention: GIC with 30% bioactive glass (group 6)
Number of subjects: 70
Study 22838229 — intervention group
Group type: EXPERIMENTAL
Intervention: GIC with 50% bioactive glass (group 7)
Number of subjects: 70
Study 20832282 — intervention group
Group type: EXPERIMENTAL
Intervention: PCEA+AMB (PCEA with AMB of 5 mL every hour)
Number of subjects: 62
Study 20832282 — intervention group
Group type: COMPARATOR
Intervention: PCEA+BI (PCEA with basal continuous infusion of 5mL/h)
Number of subjects: 62
Study 20832282 — intervention group
Group type: EXPERIMENTAL
Intervention: PCEA+AMB
Number of subjects: 62
Study 20832282 — intervention group
Group type: COMPARATOR
Intervention: PCEA+BI
Number of subjects: 62
Study 18687283 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 15925050 — intervention group
Group type: EXPERIMENTAL
Intervention: HMG
Number of subjects: 60
Study 15925050 — intervention group
Group type: COMPARATOR
Intervention: rhFSH
Number of subjects: 60
Study 12933466 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-wall puncture technique
Number of subjects: 0
Study 12933466 — intervention group
Group type: COMPARATOR
Intervention: Conventional double-wall puncture technique
Number of subjects: 0
Study 10828010 — intervention group
Group type: EXPERIMENTAL
Intervention: L-asparaginase during consolidation therapy in the medium-risk group (MRG)
Number of subjects: 2178
Study 10828010 — intervention group
Group type: COMPARATOR
Intervention: No L-asparaginase during consolidation therapy in the medium-risk group (MRG)
Number of subjects: 2178
Study 10828010 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-Gy preventive cranial radiotherapy in the medium-risk group (MRG) and high-risk group (HRG)
Number of subjects: 2178
Study 10828010 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment regimen in ALL-BFM 90
Number of subjects: 2178
Study 10828010 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-risk group (SRG) treatment regimen
Number of subjects: 2178
Study 10828010 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-risk group (MRG) treatment regimen
Number of subjects: 2178
Study 10828010 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk group (HRG) treatment regimen
Number of subjects: 2178
Study 10828010 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall improvement over results in ALL-BFM 86
Number of subjects: 2178
Study 8651156 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg of meperidine
Number of subjects: 120
Study 8651156 — intervention group
Group type: COMPARATOR
Intervention: 1 mg of midazolam
Number of subjects: 120
Study 2000050 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (clonidine plus hydralazine)
Number of subjects: 52
Study 2000050 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 6406198 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal (i.p.) insulin infusion
Number of subjects: 6
Study 6406198 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous (s.c.) insulin infusion
Number of subjects: 6
Study 6406198 — intervention group
Group type: COMPARATOR
Intervention: Intravenous (i.v.) insulin infusion
Number of subjects: 6
Study 6406198 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 6
Study 29913072 — intervention group
Group type: EXPERIMENTAL
Intervention: Stream-specific education in pediatrics, women's health, neuro-medical, musculoskeletal, cardiorespiratory, and critical care over 8 weeks (8 hours total)
Number of subjects: 18
Study 29913072 — intervention group
Group type: EXPERIMENTAL
Intervention: Stream-specific education
Number of subjects: 18
Study 31002304 — intervention group
Group type: EXPERIMENTAL
Intervention: Engagement with the website's monitoring and feedback component
Number of subjects: 230
Study 31002304 — intervention group
Group type: EXPERIMENTAL
Intervention: Percentage of earned points redeemed for financial incentives
Number of subjects: 230
Study 31002304 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency of hits on the discussion forum
Number of subjects: 230
Study 31002304 — intervention group
Group type: COMPARATOR
Intervention: Identified regulation
Number of subjects: 230
Study 31002304 — intervention group
Group type: COMPARATOR
Intervention: Recovery self‐efficacy
Number of subjects: 230
Study 31002304 — intervention group
Group type: COMPARATOR
Intervention: Perceived workplace environment safety
Number of subjects: 230
Study 31002304 — intervention group
Group type: COMPARATOR
Intervention: EuroQoL health index
Number of subjects: 230
Study 31002304 — intervention group
Group type: COMPARATOR
Intervention: Financial motivation
Number of subjects: 230
Study 31002304 — intervention group
Group type: COMPARATOR
Intervention: Perceived availability of physical activity opportunities in the workplace environment
Number of subjects: 230
Study 29078915 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental skills curriculum (MSC) group
Number of subjects: 60
Study 29078915 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 27044507 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia at 34 °C
Number of subjects: 0
Study 27044507 — intervention group
Group type: COMPARATOR
Intervention: Standard ECLS therapy at normothermia
Number of subjects: 0
Study 25280869 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted case finding for COPD
Number of subjects: 56
Study 25280869 — intervention group
Group type: EXPERIMENTAL
Intervention: Active case finding using a postal questionnaire
Number of subjects: 56
Study 25280869 — intervention group
Group type: EXPERIMENTAL
Intervention: Opportunistic-only case finding during routine surgery consultations
Number of subjects: 56
Study 25280869 — intervention group
Group type: COMPARATOR
Intervention: Routine practice
Number of subjects: 56
Study 21674765 — intervention group
Group type: EXPERIMENTAL
Intervention: Subclavian catheters
Number of subjects: 83
Study 21674765 — intervention group
Group type: COMPARATOR
Intervention: Jugular catheters
Number of subjects: 83
Study 19180072 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 522
Study 19180072 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 522
Study 17301565 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% PRO 2000 gel
Number of subjects: 24
Study 17301565 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 24
Study 15303996 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly iron supplements (108 mg iron) given for 10 weeks
Number of subjects: 1510
Study 15303996 — intervention group
Group type: COMPARATOR
Intervention: Control group (no iron supplements)
Number of subjects: 1510
Study 11235795 — intervention group
Group type: COMPARATOR
Intervention: Blood alcohol concentration of 0.00%
Number of subjects: 18
Study 11235795 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood alcohol concentration of 0.05%
Number of subjects: 18
Study 11235795 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood alcohol concentration of 0.08%
Number of subjects: 18
Study 11235795 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged wakefulness (18.5 and 21 hours)
Number of subjects: 18
Study 10468675 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg)
Number of subjects: 14
Study 10468675 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 8580276 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral nutrition
Number of subjects: 0
Study 8580276 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin
Number of subjects: 0
Study 8580276 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 0
Study 2379634 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct intraperitoneal insemination
Number of subjects: 124
Study 2379634 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrauterine insemination (IUI)
Number of subjects: 124
Study 2379634 — intervention group
Group type: COMPARATOR
Intervention: Control cycles (same couples)
Number of subjects: 124
Study 272044 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhesive Restoration
Number of subjects: 0
Study 272044 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental adhesive fillings in minimally prepared saucer-shaped cavities
Number of subjects: 0
Study 272044 — intervention group
Group type: COMPARATOR
Intervention: Other restorative techniques
Number of subjects: 0
Study 272044 — intervention group
Group type: COMPARATOR
Intervention: Enamel conditioning without sealer application
Number of subjects: 0
Study 272044 — intervention group
Group type: EXPERIMENTAL
Intervention: Utilization of a sealer
Number of subjects: 0
Study 272044 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride solution application post-restoration
Number of subjects: 0
Study 30356327 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 80
Study 30356327 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 26892667 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet computer
Number of subjects: 112
Study 26892667 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive voice response system (IVRS)
Number of subjects: 112
Study 26892667 — intervention group
Group type: EXPERIMENTAL
Intervention: Paper
Number of subjects: 112
Study 24947928 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab
Number of subjects: 45
Study 24947928 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin plus cetuximab
Number of subjects: 45
Study 24947928 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin
Number of subjects: 45
Study 24947928 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 45
Study 24947928 — intervention group
Group type: COMPARATOR
Intervention: Untreated
Number of subjects: 45
Study 23301240 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal toothpaste (Himalaya Herbal Healthcare)
Number of subjects: 60
Study 23301240 — intervention group
Group type: COMPARATOR
Intervention: Fluoridated toothpaste (Colgate Dental Cream)
Number of subjects: 60
Study 19836169 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil (5mg daily for 3 days)
Number of subjects: 0
Study 19836169 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 18202212 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS
Number of subjects: 66
Study 18202212 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Hz rTMS
Number of subjects: 66
Study 18202212 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 Hz rTMS
Number of subjects: 66
Study 18202212 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS (occipital, 1 Hz)
Number of subjects: 66
Study 16417782 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteoking (25 ml every other day for 10 days)
Number of subjects: 62
Study 16417782 — intervention group
Group type: COMPARATOR
Intervention: Sanchi‐dansheng tablets (3 tablets thrice a day for 10 days)
Number of subjects: 62
Study 16417782 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteoking
Number of subjects: 62
Study 16417782 — intervention group
Group type: COMPARATOR
Intervention: Sanchi‐dansheng tablets
Number of subjects: 62
Study 11575540 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine (2 mg/min) plus phenylephrine (10 microg/min)
Number of subjects: 39
Study 11575540 — intervention group
Group type: COMPARATOR
Intervention: Ephedrine (2 mg/min) alone
Number of subjects: 39
Study 9663418 — intervention group
Group type: COMPARATOR
Intervention: 3 x 100 mg alizapride plus placebo (group A)
Number of subjects: 96
Study 9663418 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 x 100 mg alizapride plus 3 x 4 mg dexamethasone (group B)
Number of subjects: 96
Study 8176255 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 0.05% betamethasone dipropionate applied at 1600 h for 2 or 6 hours
Number of subjects: 0
Study 8176255 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 0.05% betamethasone dipropionate
Number of subjects: 0
Study 3276238 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 0.1 mg/kg IV
Number of subjects: 80
Study 3276238 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 2285605 — intervention group
Group type: EXPERIMENTAL
Intervention: Anandron (300 mg) + orchiectomy
Number of subjects: 125
Study 2285605 — intervention group
Group type: COMPARATOR
Intervention: Placebo + orchiectomy
Number of subjects: 125
Study 773413 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% betamethasone valerate (BV)
Number of subjects: 20
Study 773413 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% clobetasol propionate (CP)
Number of subjects: 20
Study 773413 — intervention group
Group type: COMPARATOR
Intervention: Placebo preparations
Number of subjects: 20
Study 30813767 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face and booklet (F2FB)
Number of subjects: 393